Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis: Role of Heat Shock Proteins and Dissecting Effects of Hyperthermia-Reference-Cited by-同舟云学术

Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis: Role of Heat Shock Proteins and Dissecting Effects of Hyperthermia

Published:2013-03-02 Issue:4 Volume:20 Page:1105-1113
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Pelz Joerg O. W.,Vetterlein Malte,Grimmig Tanja,Kerscher Alexander G.,Moll Eva,Lazariotou Maria,Matthes Niels,Faber Marc,Germer Christoph-Thomas,Waaga-Gasser Ana Maria,Gasser Martin

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-012-2784-6.pdf

Reference36 articles.

1. Yang XJ, Li Y, Al-shammaa Hassan AH, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Ann Surg Oncol. 2009;16:345–51.

2. Hioki M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kinoshita T. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg. 2010;34:555–62.

3. Bouquet W, Boterberg T, Ceelen W, et al. In vitro cytotoxicity of paclitaxel/beta-cyclodextrin complexes for HIPEC. Int J Pharm. 2009;367:148–54.

4. Spiliotis JD. Peritoneal carcinomatosis cytoreductive surgery and HIPEC: a ray of hope for cure. Hepatogastroenterology. 2010;57:1173–7.

5. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resection Combined with Hyperthermic Intra-peritoneal Chemotherapy Prevents Peritoneal Implantation Metastasis of Hepatocellular Carcinoma with Spontaneous Rupture;2024-03-08

2. Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA);Current Oncology;2024-01-24

3. Research Progress and Clinical Application of Hyperthermic Intraperitoneal Chemotherapy in the Prevention and Treatment of Gastric Cancer Peritoneal Metastasis;Advances in Clinical Medicine;2024

4. CYTOKINE-MODULATING INFLUENCE OF HIPEC ON THE INTRAPERITONEAL HOMEOSTASIS FORMATION IN PATIENTS WITH OVARIAN CANCER;Proceeding of the Shevchenko Scientific Society. Medical Sciences;2023-12-22

5. Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases;Molecular Cancer;2023-06-14